Which has grown faster, ANIP or XRAY?

Over the past five years, ANIP grew revenue faster — ANIP at a 35.61% CAGR versus XRAY at 1.96%.

Does ANIP or XRAY pay a bigger dividend?

XRAY pays a dividend (3.74% yield), while ANIP has no payments in the available dividend history.

Is ANIP or XRAY more profitable?

ANIP runs the higher net margin — ANIP at 10.82% versus XRAY at -14.99%.

How have ANIP and XRAY total returns compared?

Over the past 10 years, ANIP delivered 0.51% and XRAY delivered -16.38% annualized total return. Past performance doesn't predict future results.

ANI Pharmaceuticals, Inc. (ANIP) vs DENTSPLY SIRONA Inc. (XRAY)

A side-by-side comparison of ANI Pharmaceuticals, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANIP

ANI Pharmaceuticals, Inc.

$1.65B

$72.58HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

XRAY

DENTSPLY SIRONA Inc.

$1.71B

$8.56HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ANIP vs XRAY

growth of $100 · dividends reinvested · last 10y

ANIP +5.2% (+0.5%/yr)XRAY -83.3% (-16.4%/yr)ANIP compounded faster over this window

Log scale — wide-divergence pair

ANIP XRAY

ANIP vs XRAY: by the numbers

•XRAY is the larger company ($1.71B vs $1.65B market cap).
•ANIP is profitable (10.82% net margin) while XRAY runs a net loss (-14.99%).
•ANIP grew revenue faster over the past five years (35.61% vs 1.96% CAGR).
•XRAY pays a dividend (3.74% yield), while ANIP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ANIP	XRAY
P/E ratio	15.68	N/A
Forward P/E	7.83	5.61
P/S ratio	1.69	0.47
P/B ratio	2.76	1.27
EV / EBITDA	6.87	4.44
FCF yield	N/A	8.34%

Profitability

Metric	ANIP	XRAY
Gross margin	51.01%	49.52%
Operating margin	15.35%	11.69%
Net margin	10.82%	-14.99%
ROE	17.72%	-40.41%
ROIC	9.26%	10.03%

Dividends

Metric	ANIP	XRAY
Dividend yield	N/A	3.74%

Growth (annualized)

Metric	ANIP	XRAY
Revenue CAGR (5Y)	35.61%	1.96%
FCF CAGR (5Y)	N/A	-25.74%
Total return CAGR (5Y)	16.86%	-30.27%

Frequently asked

Which has grown faster, ANIP or XRAY?: Over the past five years, ANIP grew revenue faster — ANIP at a 35.61% CAGR versus XRAY at 1.96%.
Does ANIP or XRAY pay a bigger dividend?: XRAY pays a dividend (3.74% yield), while ANIP has no payments in the available dividend history.
Is ANIP or XRAY more profitable?: ANIP runs the higher net margin — ANIP at 10.82% versus XRAY at -14.99%.
How have ANIP and XRAY total returns compared?: Over the past 10 years, ANIP delivered 0.51% and XRAY delivered -16.38% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANIP analysis Full XRAY analysis Interactive comparison tool

Dig into the metrics

ANI Pharmaceuticals P/E ratio DENTSPLY SIRONA dividend yield ANI Pharmaceuticals ROE DENTSPLY SIRONA ROE ANI Pharmaceuticals operating margin DENTSPLY SIRONA operating margin ANI Pharmaceuticals revenue growth DENTSPLY SIRONA revenue growth ANI Pharmaceuticals free cash flow DENTSPLY SIRONA free cash flow

ANI Pharmaceuticals & DENTSPLY SIRONA appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.